LHSC receives funding to expand stem cell transplants

July 31, 2017

London Health Sciences Centre (LHSC) will receive funding to expand access to stem cell treatments for patients in London and region.  Last week, Dr. Eric Hoskins, Minister of Health and Long-Term Care announced an investment in stem cell transplant inpatient and outpatients units at both LHSC and Princess Margaret hospitals. The funding infusion will allow LHSC to open 7 new beds, in addition to renovating and expanding cancer ambulatory clinics to enable more comprehensive care for patients. 

“With this new funding, we are helping hospitals provide life-saving stem cell treatment closer to home. The excellent work and recommendations of the Stem Cell Treatment Consultation Group has enabled the construction of these state-of-the-art facilities in Toronto and London. The government’s investment in the two new units will reduce wait times and improve care for Ontarians who need stem cell transplants.” said Hoskins.

A stem cell transplant is a procedure that replaces defective or damaged cells in patients whose normal cells have been affected by lymphoma, leukemia, myeloma and other cancers and disorders affecting the blood. There are three types of stem cell transplants: those from the patient (autologous), those taken from a related donor (allogeneic related) and those provided by an unrelated donor (allogeneic unrelated).

“London Health Sciences Centre welcomes today’s funding announcement that will enable us to fulfill our vision of expanding current services to become a comprehensive stem cell transplant centre.” said Murray Glendining, President and CEO, London Health Science Centre.  “This funding will allow our staff and physicians to better serve the people of London and region by providing specialized stem cell transplant inpatient and day treatment facilities, dedicated hematology outpatient clinics, as well as support services in plasmapheresis, laboratory services and pharmacy services.”